Prothena | PRTA - Рыночная капитализация





Рыночная капитализация Изменить Дата
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 195.44B 5.55B 2026-06
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 11.15B 91M 2026-11
Exelixis USD 14.47B 933M 2026-09
Immunic USD 64M 23M 2025-12
Incyte USD 24.6B 1.95B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
MacroGenics USD 294M 110M 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 14.54B 2.41B 2026-11
Prothena USD 513M 3M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 144.94B 18.86B 2026-11